Table 2 Comparative analysis between alive and deceased BD patients
From: Ethnicity and association with disease manifestations and mortality in Behçet’s disease
Parameters | N | Alive | N | Deceased |
|---|---|---|---|---|
729 | (n = 729) | 40 | (n = 40) | |
Age at diagnosis | 724 | 30.6 [24.6; 37.19] | 40 | 32.42 [27.0; 44.19] |
Male sex | 468 | 64.2% | 37 | 92.5% |
Genital ulcerations | 448 | 61.45% | 17 | 42.5% |
Oral ulcerations | 724 | 99.31% | 40 | 100% |
Articular involvement | 354 | 48.83% | 20 | 50% |
Ocular involvement | 482 | 66.21% | 25 | 62.5% |
CNS involvement | 229 | 31.67% | 15 | 37.5% |
Cardiovascular involvement | 301 | 41.29% | 27 | 67.5% |
Immunosuppressants | 380 | 52.13% | 30 | 75% |
Corticosteroids | 475 | 65.16% | 35 | 87.5% |
Anticoagulation | 46 | 6.31% | 3 | 7.5% |
HLAB5* | 281/538 | 52.23% | 11/30 | 36.67% |
Ethnicity | ||||
Europe | 356 | 48.83% | 13 | 32.5% |
Sub Saharan Africa | 44 | 6.04% | 6 | 15% |
North Africa | 329 | 45.13% | 21 | 52.5% |